A detailed history of New Square Capital LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, New Square Capital LLC holds 50 shares of BMY stock, worth $2,659. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 68 26.47%
Holding current value
$2,659
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$40.25 - $52.99 $724 - $953
-18 Reduced 26.47%
50 $2,000
Q1 2024

May 08, 2024

SELL
$47.98 - $54.4 $1,679 - $1,904
-35 Reduced 33.98%
68 $3,000
Q4 2023

Feb 01, 2024

SELL
$48.48 - $57.85 $20,216 - $24,123
-417 Reduced 80.19%
103 $5,000
Q3 2023

Nov 03, 2023

SELL
$57.89 - $64.73 $2,547 - $2,848
-44 Reduced 7.8%
520 $30,000
Q2 2023

Aug 03, 2023

BUY
$63.71 - $70.74 $16,628 - $18,463
261 Added 86.14%
564 $36,000
Q1 2023

May 01, 2023

BUY
$65.71 - $74.53 $13,141 - $14,906
200 Added 194.17%
303 $21,000
Q4 2022

Feb 06, 2023

SELL
$68.48 - $81.09 $13,696 - $16,218
-200 Reduced 66.01%
103 $7,000
Q3 2022

Oct 25, 2022

BUY
$0.13 - $76.84 $28 - $16,751
218 Added 256.47%
303 $22,000
Q3 2021

Nov 08, 2021

SELL
$59.17 - $69.31 $556,079 - $651,375
-9,398 Reduced 99.1%
85 $5,000
Q2 2021

Jul 28, 2021

BUY
$61.91 - $67.42 $7,119 - $7,753
115 Added 1.23%
9,483 $634,000
Q1 2021

May 10, 2021

BUY
$59.34 - $66.74 $129,420 - $145,559
2,181 Added 30.35%
9,368 $591,000
Q4 2020

Feb 04, 2021

BUY
$57.74 - $65.43 $119,521 - $135,440
2,070 Added 40.45%
7,187 $446,000
Q3 2020

Nov 04, 2020

BUY
$57.43 - $63.64 $64,149 - $71,085
1,117 Added 27.93%
5,117 $309,000
Q2 2020

Aug 05, 2020

BUY
$54.82 - $64.09 $7,674 - $8,972
140 Added 3.63%
4,000 $235,000
Q1 2020

May 08, 2020

BUY
$46.4 - $67.43 $43,384 - $63,047
935 Added 31.97%
3,860 $215,000
Q4 2019

Jan 10, 2020

BUY
$49.21 - $64.19 $138,526 - $180,694
2,815 Added 2559.09%
2,925 $188,000
Q1 2019

Apr 25, 2019

SELL
$45.12 - $53.8 $1,579 - $1,883
-35 Reduced 24.14%
110 $5,000
Q4 2018

Jan 22, 2019

BUY
$48.76 - $63.23 $7,070 - $9,168
145 New
145 $8,000
Q3 2018

Oct 19, 2018

SELL
$55.19 - $62.25 $0 - $0
0 Closed
0 $0
Q2 2018

Jul 23, 2018

SELL
$50.53 - $62.98 $3,031 - $3,778
-60 Closed
0 $0
Q4 2017

Jan 29, 2018

SELL
$59.94 - $65.35 $1.9 Million - $2.07 Million
-31,685 Reduced 99.81%
60 $4,000
Q3 2017

Nov 07, 2017

BUY
$55.23 - $63.74 $1.75 Million - $2.02 Million
31,745
31,745 $37,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track New Square Capital LLC Portfolio

Follow New Square Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Square Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Square Capital LLC with notifications on news.